Teleflex to Present at Raymond James Conference: A Look into the Company's Resilience and Growth Prospects

Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, has announced its participation in the Raymond James & Associates 46th Annual Institutional Investors Conference. The event, scheduled to take place at the JW Marriott Grande Lakes in Orlando, Florida, on Tuesday, March 4, 2025, at 3:25 p.m. (ET), will provide an opportunity for the company's management to present its latest developments and growth prospects to investors.



Teleflex's resilience and growth prospects can be attributed to its diversified portfolio, which includes solutions in various therapy areas such as anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company's commitment to purpose-driven innovation and world-class products has enabled it to develop and introduce new products that cater to the evolving needs of healthcare providers and patients.

In the third quarter of 2024, Teleflex delivered year-over-year margin expansion and continued adjusted operating income growth. The company's strong performances from Interventional and Vascular Access helped offset unexpected softness in OEM revenues. Teleflex's adjusted constant currency revenue growth was 2.2% for the same period, with a 2.4% increase in reported revenue compared to the prior year period.



Teleflex's cash flow remains strong, with total cash, cash equivalents, and restricted cash equivalents at $277.8 million as of September 29, 2024. The company has augmented its disciplined capital allocation strategy with a $500 million share repurchase authorization, including a $200 million accelerated share program in the third quarter. Teleflex's net leverage was 1.7x as of September 29, 2024, providing the company with considerable balance sheet flexibility to execute on its M&A strategy.

Teleflex's participation in the Raymond James & Associates 46th Annual Institutional Investors Conference is an opportunity for investors to gain insights into the company's recent performance, growth prospects, and strategic initiatives. The conference will provide a platform for Teleflex's management to engage with investors, analysts, and other industry professionals, discussing the company's vision for the future and its commitment to driving innovation and growth in the medical technology industry.

In conclusion, Teleflex's resilience and growth prospects are underpinned by its diversified portfolio, commitment to innovation, and strong financial performance. The company's participation in the Raymond James & Associates 46th Annual Institutional Investors Conference is an opportunity for investors to learn more about Teleflex's recent developments and growth prospects, as well as engage with the company's management and other industry professionals.